Pharmacologically regulated induction of silent mutations (PRISM): Combined pharmacological and genetic approaches for learning and memory

Paul W. Frankland, Masuo Ohno, Eiki Takahashi, Adele R. Chen, Rui M. Costa, Steven A. Kushner, Alcino J. Silva

研究成果: ジャーナルへの寄稿総説査読

6 被引用数 (Scopus)

抄録

Mouse transgenic and knock-out approaches have made fundamental contributions to our understanding of the molecular and cellular bases of learning and memory. These approaches have successfully identified a large number of molecules with either a central or modulatory role in learning and memory. However, there are limitations associated with first-generation mutant mice, which include, for example, the lack of temporal control over the mutation. Recent technical developments have started to address some of these shortcomings. Here, the authors review a newly developed inducible approach that takes advantage of synergistic interactions between subthreshold genetic and pharmacological manipulations. This approach is easily set up and can be used to study the functional interactions between molecules in signaling pathways.

本文言語英語
ページ(範囲)104-109
ページ数6
ジャーナルNeuroscientist
9
2
DOI
出版ステータス出版済み - 4月 2003
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 神経科学一般
  • 臨床神経学

フィンガープリント

「Pharmacologically regulated induction of silent mutations (PRISM): Combined pharmacological and genetic approaches for learning and memory」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル